A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) ...

Background The evidence on associations between ultra-processed foods (UPF) and lung cancer risk is limited and inconsistent. Research question Are UPF associated with an increased risk of lung cancer ...

Probably the saddest thing about our lives is that everything comes to an end. A few days ago, sadly, one of the best things that happened to the internet ended. To be more specific, Maru, the most ...

Dr. Regina Barzilay’s world turned upside down when she was diagnosed with breast cancer in 2014. It seemed to come out of nowhere. She didn’t know anyone in her family who had BRCA genes — the genes ...

The American Cancer Society (ACS) has released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate ...

A man in China became the first recipient of a pig lung. The genetically modified pig organ was transplanted into the 39-year-old, according to an Aug. 26 report by the journal Nature. The procedure ...

Aug 25 (Reuters) - Royalty Pharma (RPRX.O), opens new tab has agreed to buy a royalty interest in Amgen's (AMGN.O), opens new tab drug for small cell lung cancer from BeOne Medicines (688235.SS), ...

Scientists have, for the first time, transplanted a genetically engineered pig lung into a human. The lung tissue remained alive for nine days after the transplant despite early signs of inflammation, ...

BeOne Medicines is monetizing its stake in Amgen’s first-in-class lung cancer drug Imdelltra for up to $950 million. Royalty Pharma will pay BeOne $885 million upfront for certain royalty payments ...

In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses while reducing financial and toxicity burdens, with decisions guided by ...

Data from IDeate-Lung01 trial will be presented at upcoming IASLC 2025 World Conference on Lung Cancer First Breakthrough Therapy Designation for Daiichi Sankyo and Merck’s ifinatamab deruxtecan based ...

Gwen Orilio didn’t know how long she had to live after her stage-four lung cancer diagnosis. The disease had already infiltrated her eye, so the 31-year-old didn’t bother opening a retirement account.